Observational Study of Head and Neck Tumor Genetics
This study aims to understand the genetic makeup of head and neck tumors and how it relates to how well treatments work and your long-term outcome. Researchers will look at tumor tissue from people with head and neck tumors, both cancerous and non-cancerous. They are trying to find patterns in your genes that can predict how you will respond to treatment and your chances of recurrence (the cancer coming back) and survival over 5 years. This is an observational study, meaning no specific treatments are being tested as part of the study itself. The study is looking to enroll about 1000 participants. The current recruitment status is unclear.
- Study design
- This is an observational study with a planned enrollment of 1000 participants. It is not testing a specific drug or intervention.
- What's involved
- You would need to have actual or suspected head and neck tumors and either be planning a biopsy or surgery, or have existing tumor tissue available.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will look at your treatment response and prognosis, including time to recurrence and survival, for up to 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Molecular and Genomic Profiling of Head and Neck Tumors
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Richard V Smith, MD · PRINCIPAL_INVESTIGATOR · Montefiore Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- correlation of treatment response and prognosis (time to recurrence and survival) with genetic expression profile5 years